| Income Statement |
| Total Revenue | 90.00K |
|
| Revenues (USD) | 90.00K |
| Cost of Revenue | 36.00K |
| Gross Profit | 54.00K |
| Operating Expenses | 5.40M |
| Research and Development Expense | 3.47M |
| Selling, General and Administrative Expense | 1.93M |
| Operating Income | -5.35M |
| Interest Expense | 695.00K |
| Net Income | -13.42M |
| Net Income Common Stock | -13.42M |
| Net Income Common Stock (USD) | -13.42M |
| Consolidated Income | -13.42M |
| Earnings per Basic Share | -1.08 |
| Earnings per Basic Share (USD) | -1.08 |
| Earnings per Diluted Share | -1.08 |
| Earning Before Interest & Taxes (EBIT) | -12.73M |
| Earning Before Interest & Taxes (USD) | -12.73M |
| Weighted Average Shares | 12.38M |
| Weighted Average Shares Diluted | 12.38M |
| Balance Sheet |
| Cash and Equivalents | 9.73M |
| Cash and Equivalents (USD) | 9.73M |
| Trade and Non-Trade Receivables | 43.00K |
| Current Assets | 14.91M |
| Property, Plant & Equipment Net | 8.07M |
| Total Assets | 23.04M |
| Debt Current | 1.23M |
| Total Debt | 22.34M |
| Current Liabilities | 4.85M |
| Debt Non-Current | 21.12M |
| Total Liabilities | 47.82M |
| Accumulated Retained Earnings (Deficit) | -329.81M |
| Accumulated Other Comprehensive Income | 208.00K |
| Shareholders Equity | -24.78M |
| Shareholders Equity (USD) | -24.78M |
| Assets Non-Current | 8.13M |
| Total Debt (USD) | 22.34M |
| Inventory | 37.00K |
| Liabilities Non-Current | 42.97M |
| Trade and Non-Trade Payables | 1.14M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 517.00K |
| Net Cash Flow from Financing | 6.33M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 3.73M |
| Capital Expenditure | -1000 |
| Issuance (Purchase) of Equity Shares | 6.42M |
| Issuance (Repayment) of Debt Securities | -92.00K |
| Net Cash Flow from Investing | -1000 |
| Net Cash Flow from Operations | -2.59M |
| Effect of Exchange Rate Changes on Cash | -8.00K |
| Share Based Compensation | 1.04M |